GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0017187
|
BP
|
peptidyl-glutamic acid carboxylation
|
The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase.
|
F2,
BGLAP,
GGCX,
VKORC1
|
GO:0017196
|
BP
|
N-terminal peptidyl-methionine acetylation
|
The acetylation of the N-terminal methionine of proteins to form the derivative N-acetyl-L-methionine.
|
NAA30,
NAA25,
NAA15,
NAA60
|
GO:0018008
|
BP
|
N-terminal peptidyl-glycine N-myristoylation
|
The myristoylation of the N-terminal glycine of proteins to form the derivative N-myristoyl-glycine.
|
NMT2
|
GO:0018022
|
BP
|
peptidyl-lysine methylation
|
The methylation of peptidyl-lysine to form either the mono-, di- or trimethylated derivative.
|
METTL10,
ETFBKMT,
N6AMT2,
METTL21A
|
GO:0018023
|
BP
|
peptidyl-lysine trimethylation
|
The methylation of peptidyl-lysine to form peptidyl-N6,N6,N6-trimethyl-L-lysine.
|
ETFBKMT
|
GO:0018026
|
BP
|
peptidyl-lysine monomethylation
|
The methylation of peptidyl-lysine to form peptidyl-N6-methyl-L-lysine.
|
SETD6,
SETD7,
KMT5A
|
GO:0018027
|
BP
|
peptidyl-lysine dimethylation
|
The methylation of peptidyl-lysine to form peptidyl-N6,N6-dimethyl-L-lysine.
|
SETD7,
EHMT2
|
GO:0018032
|
BP
|
protein amidation
|
Addition of an amide group from a glycine to a protein amino acid.
|
PAM
|
GO:0018076
|
BP
|
N-terminal peptidyl-lysine acetylation
|
The acetylation of the N-terminal lysine of proteins.
|
EP300,
CREBBP,
KAT2B
|
GO:0018095
|
BP
|
protein polyglutamylation
|
The addition of one or more alpha-linked glutamyl units to the gamma carboxyl group of peptidyl-glutamic acid.
|
TTLL1
|
GO:0018101
|
BP
|
protein citrullination
|
The hydrolysis of peptidyl-arginine to form peptidyl-citrulline.
|
PADI4
|
GO:0018105
|
BP
|
peptidyl-serine phosphorylation
|
The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.
|
CDC7,
MAST4,
DCLK1,
MAPK13,
ULK1,
TNKS,
PDGFB,
PRKCB,
CDK1,
BCL2,
TDGF1,
PRKCA,
PRKACA,
CDK2,
MAPK3,
MAPK1,
AKT1,
AKT2,
TGFBR1,
TGFBR2,
PRKCI,
SYK,
MAPK8,
CSNK1A1,
CSNK1D,
MAPKAPK2,
CSNK1E,
GSK3B,
PRKX,
PLK1,
PRKDC,
PKD1,
CDK5,
PRKCQ,
PRKCD,
DMPK,
STK4,
MAPK7,
PAK2,
ILK,
CAMK2D,
MORC3,
GAS6,
PRKD1,
STK38,
RPS6KA2,
PKN1,
PKN2,
MAPK14,
MAST2,
RICTOR,
STK32C,
UHMK1,
SGK3,
MASTL,
SMG1,
MKNK1,
PINK1,
PRKD2,
HIPK2,
MKNK2,
NEK6,
CSNK1G1,
LATS2,
PLK2,
TBK1,
AKT3,
STK38L,
CAB39,
CSNK1G3
|
GO:0018106
|
BP
|
peptidyl-histidine phosphorylation
|
The phosphorylation of peptidyl-histidine to form peptidyl-1'-phospho-L-histidine (otherwise known as tau-phosphohistidine, tele-phosphohistidine) or peptidyl-3'-phospho-L-histidine (otherwise known as pi-phosphohistidine, pros-phosphohistidine).
|
NME2
|
GO:0018107
|
BP
|
peptidyl-threonine phosphorylation
|
The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
CHEK1,
TNKS,
CDK1,
BCL2,
PRKACA,
CAD,
MAPK1,
AKT1,
ACVR1B,
TGFBR1,
TGFBR2,
MAPK8,
GSK3B,
CDK5,
ACVR1,
PRKCD,
CAMK2D,
OSR1,
HIPK2,
WNK1,
NLK
|
GO:0018108
|
BP
|
peptidyl-tyrosine phosphorylation
|
The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
|
MAP2K7,
EREG,
MUSK,
RIPK2,
JAK2,
FGF18,
ERLIN2,
EGFR,
PDGFB,
ERBB2,
NTRK1,
INSR,
FYN,
CSF1R,
HSP90AA1,
LYN,
MET,
FGF2,
PDGFRB,
FGR,
KIT,
BCR,
FGFR1,
PDGFRA,
FGF7,
FGFR2,
ERBB3,
EPHA3,
EPHB2,
LTK,
WEE1,
FGF9,
TTK,
BTC,
TIE1,
FLT4,
MAP2K2,
STAT5A,
ABL2,
IL12RB1,
CLK2,
STAT5B,
JAK3,
MAP2K6,
EPHA5,
EPHB4,
EPHB1,
EPHA4,
IL5RA,
ROR1,
NRG1,
MAP2K1,
TEK,
PTK2,
PRKCD,
TYRO3,
EFEMP1,
MERTK,
MAP2K5,
CUX1,
MELK,
ERBB4,
TESK1,
CDC37,
NTRK2,
DSTYK,
SGK223,
ABI1,
TTN,
DYRK2,
SCYL1,
NEK1,
HBEGF,
CLK4,
FGFR1OP2,
ABI2,
ZMYM2,
EPHA6,
BAZ1B
|
GO:0018117
|
BP
|
protein adenylylation
|
The addition of an adenylyl group (adenosine 5'-monophosphate; AMP) to a protein amino acid.
|
FICD
|
GO:0018119
|
BP
|
peptidyl-cysteine S-nitrosylation
|
The covalent addition of a nitric oxide (NO) group to the sulphur (S) atom of a cysteine residue in a protein, to form peptidyl-S-nitrosyl-L-cysteine.
|
S100A8
|
GO:0018125
|
BP
|
peptidyl-cysteine methylation
|
The methylation of peptidyl-cysteine to form peptidyl-S-methyl-L-cysteine.
|
RAB3B
|
GO:0018126
|
BP
|
protein hydroxylation
|
The addition of a hydroxy group to a protein amino acid.
|
EGLN3
|
GO:0018146
|
BP
|
keratan sulfate biosynthetic process
|
The chemical reactions and pathways resulting in the formation of keratan sulfate, a glycosaminoglycan with repeat units consisting of beta-1,4-linked D-galactopyranosyl-beta-(1,4)-N-acetyl-D-glucosamine 6-sulfate and with variable amounts of fucose, sialic acid and mannose units; keratan sulfate chains are covalently linked by a glycosidic attachment through the trisaccharide galactosyl-galactosyl-xylose to peptidyl-threonine or serine residues.
|
B4GALT5,
B4GAT1,
B4GALT4,
B4GALT1,
OGN,
LUM,
FMOD,
ST3GAL1,
ST3GAL3,
ST3GAL4,
ST3GAL2,
SLC35D2,
B3GNT7,
OMD,
CHST5,
CHST6,
B3GNT2,
B4GALT6,
ST3GAL6,
CHST2
|
GO:0018149
|
BP
|
peptide cross-linking
|
The formation of a covalent cross-link between or within protein chains.
|
F13A1,
CSTA,
COL3A1,
FN1,
ANXA1,
THBS1,
DSP,
SPRR2B,
TGM4,
SPRR2G,
SPRR3
|
GO:0018153
|
BP
|
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine
|
The formation of an isopeptide cross-link between peptidyl-lysine and peptidyl-glutamine to produce N6-(L-isoglutamyl)-L-lysine.
|
TGM2
|
GO:0018158
|
BP
|
protein oxidation
|
The modification of a protein amino acid by oxidation.
|
APOA1,
APOA2,
GPX1
|
GO:0018193
|
BP
|
peptidyl-amino acid modification
|
The alteration of an amino acid residue in a peptide.
|
ASPH,
ASPHD1,
ASPHD2,
MINA
|
GO:0018205
|
BP
|
peptidyl-lysine modification
|
The modification of peptidyl-lysine.
|
MDM2
|
GO:0018206
|
BP
|
peptidyl-methionine modification
|
The modification of peptidyl-methionine.
|
APOA1,
APOA2,
METAP2
|
GO:0018216
|
BP
|
peptidyl-arginine methylation
|
The addition of a methyl group to an arginine residue in a protein.
|
PRMT1
|
GO:0018230
|
BP
|
peptidyl-L-cysteine S-palmitoylation
|
The covalent attachment of a palmitoyl group to a sulfur (S) atom within a cysteine residue to form peptidyl-S-palmitoyl-L-cysteine.
|
ZDHHC7,
ZDHHC9
|
GO:0018242
|
BP
|
protein O-linked glycosylation via serine
|
The glycosylation of protein via the O3 atom of peptidyl-serine, forming O3-glycosyl-L-serine; the most common forms are N-acetylgalactosaminyl, mannosyl, galactosyl, and xylosyl serine.
|
GALNT2,
GALNT1
|
GO:0018243
|
BP
|
protein O-linked glycosylation via threonine
|
The glycosylation of protein via the O3 atom of peptidyl-threonine, forming O3-glycosyl-L-threonine; the most common forms are N-acetylgalactosaminyl, mannosyl, and galactosyl threonine.
|
GALNT2,
GALNT1
|
GO:0018272
|
BP
|
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine
|
The modification of peptidyl-lysine to form N6-pyridoxal phosphate-L-lysine.
|
CTH
|
GO:0018277
|
BP
|
protein deamination
|
The removal of an amino group from a protein amino acid.
|
LOXL1,
LOXL2
|
GO:0018279
|
BP
|
protein N-linked glycosylation via asparagine
|
The glycosylation of protein via the N4 atom of peptidyl-asparagine forming N4-glycosyl-L-asparagine; the most common form is N-acetylglucosaminyl asparagine; N-acetylgalactosaminyl asparagine and N4 glucosyl asparagine also occur. This modification typically occurs in extracellular peptides with an N-X-(ST) motif. Partial modification has been observed to occur with cysteine, rather than serine or threonine, in the third position; secondary structure features are important, and proline in the second or fourth positions inhibits modification.
|
ST6GAL1,
DDOST,
STT3A,
VCP,
DAD1,
MGAT2,
ST3GAL1,
ST3GAL3,
ST3GAL4,
ST3GAL2,
SYVN1,
MCFD2,
STT3B,
ST6GAL2,
ST6GALNAC5,
FUT8,
ST6GALNAC4,
OSTC,
UGGT1,
DPM3,
ST6GALNAC2,
ST3GAL6
|
GO:0018283
|
BP
|
iron incorporation into metallo-sulfur cluster
|
The incorporation of iron into a metallo-sulfur cluster.
|
FXN
|
GO:0018298
|
BP
|
protein-chromophore linkage
|
The covalent or noncovalent attachment of a chromophore to a protein.
|
AMBP,
OPN1SW,
CRY1,
OPN3
|
GO:0018315
|
BP
|
molybdenum incorporation into molybdenum-molybdopterin complex
|
The incorporation of molybdenum into a molybdenum-molybdopterin complex.
|
GPHN
|
GO:0018344
|
BP
|
protein geranylgeranylation
|
The covalent attachment of a geranylgeranyl group to a protein.
|
CHM,
CHML,
PGGT1B,
RABGGTB
|
GO:0018345
|
BP
|
protein palmitoylation
|
The covalent attachment of a palmitoyl group to a protein.
|
ZDHHC20,
ZDHHC17,
ZDHHC14,
ZDHHC6,
ZDHHC7,
ZDHHC2,
ZDHHC9
|
GO:0018393
|
BP
|
internal peptidyl-lysine acetylation
|
The addition of an acetyl group to a non-terminal lysine residue in a protein.
|
EP300,
KAT2B
|
GO:0018394
|
BP
|
peptidyl-lysine acetylation
|
The acetylation of peptidyl-lysine.
|
BLOC1S1,
KAT2B
|
GO:0018395
|
BP
|
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine
|
The hydroxylation of peptidyl-lysine to peptidyl-5-hydroxy-L-lysine.
|
JMJD6
|
GO:0018400
|
BP
|
peptidyl-proline hydroxylation to 3-hydroxy-L-proline
|
The modification of peptidyl-proline to form 3-hydroxy-L-proline; catalyzed by procollagen-proline 3-dioxygenase.
|
CRTAP
|
GO:0018401
|
BP
|
peptidyl-proline hydroxylation to 4-hydroxy-L-proline
|
The modification of peptidyl-proline to form 4-hydroxy-L-proline; catalyzed by procollagen-proline,2-oxoglutarate-4-dioxygenase.
|
P4HB,
P4HA1,
EGLN3
|
GO:0018406
|
BP
|
protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan
|
The glycosylation of a peptidyl-tryptophan residue by the transfer of alpha-mannopyranose from dolichyl-activated mannose to the indole ring.
|
DPY19L2,
DPY19L3,
DPY19L4,
DPM3
|
GO:0018872
|
BP
|
arsonoacetate metabolic process
|
The chemical reactions and pathways involving arsonoacetate, a synthetic, organic compound containing a single arsenic atom. Arsonoacetate and other arsenic containing compounds are used in agricultural applications as animal feed additives, cotton defoliants and post-emergence grass herbicides.
|
AS3MT
|
GO:0018879
|
BP
|
biphenyl metabolic process
|
The chemical reactions and pathways involving biphenyl, a toxic aromatic hydrocarbon used as a heat transfer agent, as a fungistat in packaging citrus fruits and in plant disease control. Biphenyl can be chlorinated with 1-10 chlorine molecules to form polychlorinated biphenyls (PCBs).
|
SRD5A2,
STAR
|
GO:0018885
|
BP
|
carbon tetrachloride metabolic process
|
The chemical reactions and pathways involving carbon tetrachloride, a toxic, carcinogenic compound which is used as a general solvent in industrial degreasing operations. It is also used as grain fumigant and a chemical intermediate in the production of refrigerants.
|
CYP2E1
|
GO:0018894
|
BP
|
dibenzo-p-dioxin metabolic process
|
The chemical reactions and pathways involving dibenzo-p-dioxin, a substance composed of two benzene rings linked by two ether bonds. Dibenzo-p-dioxins are generated as by-products in the manufacturing of herbicides, insecticides, fungicides, paper pulp bleaching, and in incineration, and can accumulate in milk and throughout the food chain, creating significant health concern.
|
SRD5A2,
STAR
|
GO:0018910
|
BP
|
benzene metabolic process
|
The chemical reactions and pathways involving benzene, C6H6, a volatile, very inflammable liquid, contained in the naphtha produced by the destructive distillation of coal, from which it is separated by fractional distillation.
|
CYP2E1
|
GO:0018916
|
BP
|
nitrobenzene metabolic process
|
The chemical reactions and pathways involving nitrobenzene (nitrobenzol), a derivative of benzene with an NO2 group attached to the ring. It is a yellow aromatic liquid used in perfumery and manufactured in large quantities in the preparation of aniline.
|
GSTM1,
GSTM3,
GSTM2,
GSTM4
|
GO:0018931
|
BP
|
naphthalene metabolic process
|
The chemical reactions and pathways involving naphthalene, a fused ring bicyclic aromatic hydrocarbon commonly found in crude oil and oil products. Naphthalene is familiar as the compound that gives mothballs their odor; it is used in the manufacture of plastics, dyes, solvents, and other chemicals, as well as being used as an antiseptic and insecticide.
|
AKR1B1
|
GO:0018958
|
BP
|
phenol-containing compound metabolic process
|
The chemical reactions and pathways involving a phenol, any compound containing one or more hydroxyl groups directly attached to an aromatic carbon ring.
|
STAR
|
GO:0018963
|
BP
|
phthalate metabolic process
|
The chemical reactions and pathways involving phthalate, the anion of phthalic acid. Phthalic acid diesters are used industrially in the production of a variety of household and consumer goods including plastic polymers, lubricating oils, and carriers for perfumes in cosmetics, while phthalic acid itself is used industrially as a plasticizer. Terephthalate is used in the synthesis of polyethylene terephthalate (polyethene terephthlate, abbreviated PET or PETE), a plastic polymer with many commercial uses.
|
TH,
SRD5A2,
STAR
|
GO:0019046
|
BP
|
release from viral latency
|
The process by which a virus switches from latency and begins to replicate. It may be effected by various endogenous and exogenous stimuli, including B-cell lipopolysaccharides, glucocorticoid hormones, halogenated pyrimidines, ionizing radiation, ultraviolet light, various chemicals and super-infecting viruses.
|
NUCKS1
|
GO:0019048
|
BP
|
modulation by virus of host morphology or physiology
|
The process in which a virus effects a change in the structure or processes of its host organism.
|
VAPB,
DAG1,
HIPK2,
CD209
|
GO:0019049
|
BP
|
evasion or tolerance of host defenses by virus
|
Any process, either active or passive, by which a virus avoids or tolerates the effects of its host organism's defense(s). Host defenses may be induced by the presence of the virus or may be preformed (e.g. physical barriers). The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
TGFB1,
SMAD3
|
GO:0019050
|
BP
|
suppression by virus of host apoptotic process
|
Any viral process that inhibits apoptosis of infected host cells, facilitating prolonged cell survival during viral replication.
|
BAD
|
GO:0019054
|
BP
|
modulation by virus of host process
|
The process in which a virus effects a change in the processes and activities of its host organism.
|
KPNA3,
KPNA4,
KPNA5,
KPNA2,
KPNA1,
KPNB1
|
GO:0019058
|
BP
|
viral life cycle
|
A set of processes which all viruses follow to ensure survival; includes attachment and entry of the virus particle, decoding of genome information, translation of viral mRNA by host ribosomes, genome replication, and assembly and release of viral particles containing the genome.
|
VPS37C,
CHMP2A,
VPS4B,
FURIN,
UBC,
PPIA,
RPS27A,
UBA52,
VPS37A,
PDCD6IP,
PCSK5,
NEDD4L,
CHMP4B,
VTA1
|
GO:0019060
|
BP
|
intracellular transport of viral protein in host cell
|
The directed movement of a viral protein within the host cell.
|
DYNLT1
|
GO:0019061
|
BP
|
uncoating of virus
|
The process by which an incoming virus is disassembled in the host cell to release a replication-competent viral genome.
|
PPIA
|
GO:0019062
|
BP
|
virion attachment to host cell
|
The process by which a virion protein binds to molecules on the host cellular surface or host cell surface projection.
|
HSP90AB1,
CD209
|
GO:0019064
|
BP
|
fusion of virus membrane with host plasma membrane
|
Fusion of a viral membrane with the host cell membrane during viral entry. Results in release of the virion contents into the cytoplasm.
|
CD4,
CXCR4,
PPIA,
HYAL2,
GAS6
|
GO:0019065
|
BP
|
receptor-mediated endocytosis of virus by host cell
|
Any receptor-mediated endocytosis that is involved in the uptake of a virus into a host cell; successive instances of virus endocytosis result in the accumulation of virus particles within the cell.
|
EPS15,
CAV2,
CAV1
|
GO:0019068
|
BP
|
virion assembly
|
A late phase of the viral life cycle during which all the components necessary for the formation of a mature virion collect at a particular site in the cell and the basic structure of the virus particle is formed.
|
APOE,
UBC,
RAB1A,
PPIA,
RPS27A,
UBA52,
USP6NL,
RAB1B
|
GO:0019074
|
BP
|
viral RNA genome packaging
|
The packaging of viral RNA (single-stranded or double-stranded) into a nucleocapsid.
|
PC
|
GO:0019075
|
BP
|
virus maturation
|
The refolding and structural rearrangements of virion parts to transition from the intermediate virion to the more mature virion. Maturation usually involves proteolysis events and changes in the folding of the virion proteins. Can occur inside the host cell or after release.
|
MVB12A
|
GO:0019076
|
BP
|
viral release from host cell
|
The dissemination of mature viral particles from the host cell, e.g. by cell lysis or the budding of virus particles from the cell membrane.
|
VPS4B,
RAB7A,
IST1,
PPIA,
PPID
|
GO:0019079
|
BP
|
viral genome replication
|
Any process involved directly in viral genome replication, including viral nucleotide metabolism.
|
CCL2,
DEK,
VCP,
CTBP2,
GAS6,
CD209
|
GO:0019081
|
BP
|
viral translation
|
A process by which viral mRNA is translated into viral protein, using the host cellular machinery.
|
EIF2AK4
|
GO:0019082
|
BP
|
viral protein processing
|
Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a viral protein.
|
FURIN
|
GO:0019083
|
BP
|
viral transcription
|
The process by which a viral genome, or part of a viral genome, is transcribed within the host cell.
|
NUPL2,
NUP155,
RPLP1,
RPLP2,
RPLP0,
RPS17,
RPSA,
TPR,
RPS2,
RPL35A,
RPL7,
RPL17,
RPS4Y1,
RPL13,
RPL10,
RPL12,
RPL22,
RPL4,
NUP62,
RPL13A,
RPS27,
RPL35,
RPL27A,
RPL5,
RPL21,
RPL28,
RPS9,
RPS5,
RPS10,
RPL29,
RPL34,
NUP153,
RANBP2,
RPL14,
NUP107,
RPS20,
RPS3A,
RPL26,
RPL15,
RPL27,
RPL37A,
RPL37,
RPS7,
RPS8,
RPS15A,
RPS16,
RPS14,
RPS18,
RPS13,
RPS11,
RPL7A,
RPL23A,
RPS6,
RPS25,
RPS26,
RPL30,
RPL31,
RPL10A,
RPL32,
RPL11,
RPL41,
RPS27A,
UBA52,
RPL38,
RPS21,
RAE1,
RPL24,
RPL36A,
RPL19,
RPL18A,
RPL18,
NUP160,
NUP93,
NUP43,
NUP37,
NUP35,
NUP210,
NUP205,
SEH1L,
NUP88,
NDC1,
NUP58,
NUP85,
NUP50,
RPL36
|
GO:0019085
|
BP
|
early viral transcription
|
The first phase of viral transcription that occurs after entry of the virus into the host cell, but prior to viral genome replication. It involves the transcription of genes for non-structural proteins, and for lytic viruses, the early gene products are involved in establishing control over the host cell.
|
CCNT2
|
GO:0019086
|
BP
|
late viral transcription
|
The transcription of the final group of viral genes of the viral life cycle, following middle transcription, or where middle transcription doesn't occur, following early transcription. Involves the transcription of genes encoding structural proteins.
|
CCNT2,
USF2
|
GO:0019087
|
BP
|
transformation of host cell by virus
|
Any virus-induced change in the morphological, biochemical, or growth parameters of a cell.
|
INSR,
HYAL2
|
GO:0019088
|
BP
|
immortalization of host cell by virus
|
A virus-induced cellular transformation arising in immortalized cells, or cells capable of indefinite replication, due to their ability to produce their own telomerase.
|
TYMS
|
GO:0019100
|
BP
|
male germ-line sex determination
|
The determination of sex and sexual phenotype in a male organism's germ line.
|
SOX9,
MAP3K4
|
GO:0019101
|
BP
|
female somatic sex determination
|
The determination of sex and sexual phenotypes in a female organism's soma.
|
FOXL2
|
GO:0019102
|
BP
|
male somatic sex determination
|
The determination of sex and sexual phenotypes in a male organism's soma.
|
AR
|
GO:0019216
|
BP
|
regulation of lipid metabolic process
|
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving lipids.
|
PLPP1,
IRS4,
EDF1,
H2AFY,
SERPINA3,
PSAP,
NR1D1,
ID2,
NR1D2,
LSR,
GOLM1,
ADIPOR1,
IRS2,
DNAJC15
|
GO:0019217
|
BP
|
regulation of fatty acid metabolic process
|
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving fatty acids.
|
SREBF1,
CAV1,
PANK2
|
GO:0019218
|
BP
|
regulation of steroid metabolic process
|
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving steroids.
|
RORA,
STAT5B
|
GO:0019221
|
BP
|
cytokine-mediated signaling pathway
|
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
SOCS2,
SOCS3,
SOCS6,
TNFSF11,
EREG,
SOCS1,
FLRT2,
JAK2,
SOCS5,
KRAS,
IFNA1 ,
IL1A,
IL1B,
PF4,
IFNA16,
IL6,
CSF1R,
DCN,
IL6R,
KIT,
GHR,
CCL2,
EDN2,
BGN,
IL1R2,
IL6ST,
STAT3,
IL12RB1,
LIFR,
RELA,
IL10RB,
PODN,
RTN4RL1,
LRRTM4,
IFNE,
ZNF675,
ZC3H15,
BAD,
CSF3R,
LRRC19,
GREM2,
DUOX2,
DUOX1,
IL17RB,
IL37,
FLRT3,
FLRT1,
CLCF1,
IRAK3
|
GO:0019222
|
BP
|
regulation of metabolic process
|
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism.
|
NPBWR1
|
GO:0019226
|
BP
|
transmission of nerve impulse
|
The neurological system process in which a signal is transmitted through the nervous system by a combination of action potential propagation and synaptic transmission.
|
S1PR1,
CACNG8,
JAM3,
SPTBN4
|
GO:0019227
|
BP
|
neuronal action potential propagation
|
The propagation of an action potential along an axon, away from the soma.
|
NRCAM
|
GO:0019228
|
BP
|
neuronal action potential
|
An action potential that occurs in a neuron.
|
KCNA1,
ANK3,
SCN9A,
GPER1,
P2RX4
|
GO:0019229
|
BP
|
regulation of vasoconstriction
|
Any process that modulates the frequency, rate or extent of reductions in the diameter of blood vessels.
|
AGT,
EDN1,
ACE,
ADRA2B,
EDN2,
AGTR1,
HRH1,
ECE1,
ATP1A2,
ASIC2
|
GO:0019230
|
BP
|
proprioception
|
The series of events by which an organism senses the position, location, orientation, and movement of the body and its parts. Proprioception is mediated by proprioceptors, sensory nerve terminals found in muscles, tendons, and joint capsules, which give information concerning movements and position of the body. The receptors in the labyrinth are sometimes also considered proprioceptors.
|
FXN
|
GO:0019233
|
BP
|
sensory perception of pain
|
The series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal. Pain is medically defined as the physical sensation of discomfort or distress caused by injury or illness, so can hence be described as a harmful stimulus which signals current (or impending) tissue damage. Pain may come from extremes of temperature, mechanical damage, electricity or from noxious chemical substances. This is a neurological process.
|
PENK,
EDN1,
MME,
UCHL1,
IAPP,
CNR1,
NPY1R,
MAPK3,
MAPK1,
PTGS2,
OPRL1,
NMU,
CDK5,
GRIN2A,
SCN9A,
P2RX4,
NIPSNAP1
|
GO:0019240
|
BP
|
citrulline biosynthetic process
|
The chemical reactions and pathways resulting in the formation of citrulline, N5-carbamoyl-L-ornithine, an alpha amino acid not found in proteins.
|
CAD,
ALDH18A1
|
GO:0019242
|
BP
|
methylglyoxal biosynthetic process
|
The chemical reactions and pathways resulting in the formation of methylglyoxal, CH3-CO-CHO, the aldehyde of pyruvic acid.
|
GPI
|
GO:0019243
|
BP
|
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione
|
The chemical reactions and pathways resulting in the breakdown of methylglyoxal, CH3-CO-CHO, into D-lactate via the intermediate S-lactoyl-glutathione. Glutathione is used in the first step of the pathway and then regenerated in the second step.
|
HAGH,
PNKD,
PDDC1
|
GO:0019249
|
BP
|
lactate biosynthetic process
|
The chemical reactions and pathways resulting in the formation of lactate, the anion of lactic acid.
|
PDDC1
|
GO:0019254
|
BP
|
carnitine metabolic process, CoA-linked
|
The chemical reactions and pathways involving carnitine, where metabolism is linked to CoA.
|
CRAT
|
GO:0019255
|
BP
|
glucose 1-phosphate metabolic process
|
The chemical reactions and pathways involving glucose 1-phosphate, a monophosphorylated derivative of glucose with the phosphate group attached to C-1.
|
UGP2
|
GO:0019262
|
BP
|
N-acetylneuraminate catabolic process
|
The chemical reactions and pathways resulting in the breakdown of N-acetylneuraminate, the anion of 5-(acetylamino)-3,5-dideoxy-D-glycero-D-galacto-non-3-ulosonic acid.
|
GNPDA1,
NPL
|
GO:0019264
|
BP
|
glycine biosynthetic process from serine
|
The chemical reactions and pathways resulting in the formation of glycine from other compounds, including serine.
|
SHMT1
|
GO:0019265
|
BP
|
glycine biosynthetic process, by transamination of glyoxylate
|
The chemical reactions and pathways resulting in the formation of glycine by the transamination of glyoxylate.
|
AGXT
|
GO:0019276
|
BP
|
UDP-N-acetylgalactosamine metabolic process
|
The chemical reactions and pathways involving UDP-N-acetylgalactosamine, a substance composed of N-acetylgalactosamine, a common structural unit of oligosaccharides, in glycosidic linkage with uridine diphosphate.
|
CSGALNACT1
|